pretickt

VCYT peers and competitors

Veracyte, Inc. · end-of-day data as of Nov 13, 2026

Veracyte
VCYT · $1.96B
$24.33-1.2%
Nov 13, 2026 · close
$40SepOctNov9:3016:003 months -40.2%Nov 13 · close
▲ 7
  • PT$54.14 +122.5%
  • ConsensusBuy · 14
  • P/E vs own-58.8%
  • P/E vs sector-51.0%
  • FCF yield+8.2%
  • RSI28
  • Sector▲ +15.9%
Neutral
  • Earnings in103d
  • P/E15.8x
  • Support-4.4%
  • Resistance+8.5%
  • Off 52w high-60.1%
  • Volume0.8x
  • Bollingerlower half
  • News0.00
  • Trendsideways
  • 52w range$22–$61
  • ATR+14.5%
  • Off ATH-71.7%
▼ 4
  • Insiders-$2.86M
  • MAs0 of 4
  • MA20×50Death 3d ago
  • MACD-2.50

Updates with the 15-min delayed price. Not a forecast or investment advice.

The peers of Veracyte VCYT by industry and size include Idexx Laboratories IDXX, Agilent A and Natera NTRA. Among these 12 companies Veracyte VCYT ranks 12th by market cap ($1.96B); its P/E of 15.8 compares with a median of 36.6 for its peers.

Peers by industry and size

20D
1IDXXIdexx Laboratories$704.23+0.9%-8.5%+5.3%47.8$55.48B
2AAgilent$173.96+0.5%-4.9%+0.2%34.2$49.05B
3NTRANatera$319.09-1.2%-27.1%+23.2%—$46.27B
4WATWaters$460.25-0.4%-4.8%+0.3%197.5$45.24B
5IQVIQVIA$265.12-2.2%-6.8%+6.8%32.2$43.69B
6MTDMettler-Toledo$1,738.91+0.5%-3.7%-11.9%37.7$34.59B
7ILMNIllumina$207.01-1.2%-33.1%+11.2%35.6$31.3B
8LHLabcorp$370.48-0.5%-1.2%+0.8%30.4$30.08B
9DGXQuest Diagnostics$259.600.0%-0.9%-3.8%25.9$28.56B
10RVTYRevvity$154.39-1.7%-10.1%-16.1%68.3$17.24B
11CRLCharles River Laboratories$337.97-0.8%-11.0%-3.7%371.4$16.19B
12VCYTVeracyte$24.33-1.2%-60.1%+122.5%15.8$1.96B

Data as of Nov 13, 2026 close.